Western Asset Glbl Partners Incm Fnd Inc  

(Public, NYSE:GDF)   Watch this stock  
Find more results for GDF
13.44
0.00 (0.02%)
May 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 13.39 - 13.52
52 week 11.51 - 14.05
Open 13.51
Vol / Avg. 29,188.00/31,586.00
Mkt cap 207.38M
P/E     -
Div/yield 0.09/8.26
EPS     -
Shares 15.43M
Beta 0.78
Inst. own 8%

Key stats and ratios

2011
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets - -
Return on average equity - -
Carbon Disclosure Rating - -

Address

LEGG MASON & CO LLC, 49TH FLOOR, 620 EIGHTH AVENUE
NEW YORK, NY 10018
United States - Map

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Western Asset Global Partners Income Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund�s investment objective is to maintain a high level of current income by investing primarily in a portfolio of high-yield United States and non-United States corporate debt securities and high-yield foreign sovereign debt securities. As a secondary objective, the Fund seeks capital appreciation.

Officers and directors

R. Jay Gerken CFA Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Richard F. Sennett Principal Financial Officer
Age: 43
Bio & Compensation  - Reuters
Ted P. Becker Chief Compliance Officer
Age: 62
Bio & Compensation  - Reuters
Steven Frank Treasurer
Age: 46
Bio & Compensation  - Reuters
Vanessa A. Williams Identity Theft Prevention Officer
Age: 34
Bio & Compensation  - Reuters
Robert I. Frenkel Secretary, Chief Legal Officer
Age: 59
Bio & Compensation  - Reuters
Jeswald W. Salacuse Lead Independent Director
Age: 75
Bio & Compensation  - Reuters
Eileen A. Kamerick Director
Age: 55
Bio & Compensation  - Reuters
Carol L. Colman Independent Director
Age: 67
Bio & Compensation  - Reuters
Daniel P. Cronin Independent Director
Age: 67
Bio & Compensation  - Reuters